Preserving fertility in patients malignant

Abstract

Fertility preservation is becoming increasingly important to improve the quality of life of cancer survivors. Although the guidelines state that discussion about fertility preservation should take place before starting cancer treatment, a variety of fertility preservation techniques are available at this time that can be used individually or together on the same patient to increase efficiency. Cryopreservation of eggs and embryos is now an established technique with limitations. Cryopreservation of ovarian tissue is currently experimental, but has the advantage of having a wider clinical application and keeping the fertility window open for as long as possible. Both chemotherapy and radiotherapy have a significant impact on fertility and fertility preservation measures must be taken before these treatments. The need for fertility preservation should be considered, taking into account the morbidity and mortality associated with cancer. Therefore, a multidisciplinary collaboration is needed between oncologists and obstetricians and oncologists to improve awareness of maintaining malignant cancer patients in good fertility that enables them to conceive and give birth.